
Drugmaker Indivior drops London listing to cut costs
(Reuters) -Pharma firm Indivior said on Monday it will cancel its secondary listing on the London St...
2nd June, 2025

(Reuters) -Pharma firm Indivior said on Monday it will cancel its secondary listing on the London St...
2nd June, 2025
(Reuters) -European shares opened lower on Monday, after rounding off monthly gains in May, as U.S....
2nd June, 2025
ROME (Reuters) -Italy's manufacturing sector showed tentative signs of stabilisation in May, as outp...
2nd June, 2025
(Reuters) -Polish equities slipped on Monday after nationalist opposition candidate Karol Nawrocki w...
2nd June, 2025
ZURICH (Reuters) -The Swiss economy grew by 0.8% in the first three months of 2025, the government s...
2nd June, 2025
(Reuters) -U.S. President Donald Trump said on Friday he planned to double tariffs on steel and alum...
2nd June, 2025
WARSAW (Reuters) -Polish nationalist opposition candidate Karol Nawrocki won Sunday's second round o...
2nd June, 2025
By Dhara Ranasinghe and Stefano Rebaudo LONDON (Reuters) -The European Central Bank is tipped to cut...
2nd June, 2025
By Wayne Cole SYDNEY (Reuters) - Asian share markets made a wary start to the week on Monday as inve...
2nd June, 2025
By Kevin Buckland TOKYO (Reuters) -The U.S. dollar edged lower on Monday, giving back some of its ga...
2nd June, 2025
By Florence Tan SINGAPORE (Reuters) - Oil prices rebounded more than $1 a barrel in early Asian trad...
1st June, 2025

By Ted Hesson WASHINGTON (Reuters) -U.S. Commerce Secretary Howard Lutnick downplayed the impact of...
1st June, 2025